TMS now covered under Medicare for Treatment resistant depression

Updated: Nov 25, 2021

After many years of hard work by psychiatrists across Australia, the Australian Government has agreed to invest signficant amounts of money into this drug-free treatment. To learn more about rTMS and whether you are eligible please visit Neuralia TMS and their Perth TMS clinics

From 1 November 2021, new items for Repetitive Transcranial Magnetic Stimulation (rTMS) therapy services will be added to the Medicare Benefits Schedule (MBS) for eligible patients with diagnosed medication-resistant major depressive disorder. The four new items will make MBS subsidised rTMS therapy available for patients over the age of 18 years who have tried at least two classes of antidepressants and remain unwell, and have not received rTMS therapy previously.

At introduction, MBS rebates will be available for the prescription and delivery of up to 35 rTMS sessions in an initial treatment course, and the prescription and delivery of a retreatment course of up to 15 sessions for patients who have showed improvement in an initial but subsequently relapsed.